Leading companies spent around 4.5% (2018) of their yearly revenue on research and development, and the numbers keep rising, according to the PwC Global Innovation 1000 Study. No doubt, corporations will continue to research market trends and uncover hard-to-get information to empower better decision-making. Companies typically rely on these 6 common tools to facilitate their […]
Read More
by Kenny Dolgin, Data Insights, Guidepoint Edwards Lifesciences Corp. (NYSE: EW) is a leader in the approximately $3 billion transcatheter heart valve (THV) market, having launched their first SAPIEN valve in the U.S. in 2011 and now having released their third generation valve. From 2013 to 2017, Edwards’ stock price delivered a 5-year CAGR of […]
Read More
Zimmer Biomet’s (NYSE: ZBH) US sales have declined every quarter since Q4 2016. After stating their expectations to make significant progress on remediating their supply issues during the first two quarters of 2017, Zimmer management was unable to meet those expectations and delayed their resolution timeline numerous times. The company missed consensus top-line estimates again […]
Read More
Originally published in Private Debt Investor © 2015 Private Debt Investor, PEI Media As direct lending attracts more potential customers, lenders are tapping vertical industry experts to help them efficiently assess opportunities. Michael Ferrari, head of new client development at Guidepoint, explores the trend. Direct lending continues to be identified as one of the most […]
Read More纽约 | 波士顿 | 旧金山 | 伦敦 | 杜塞尔多夫 | 新加坡 | 上海 | 香港 | 首尔 | 东京
